Association between Type 2 Diabetes and Elevaton of Liver Enzymes
Main Article Content
Abstract
Millions of people throughout the world are impacted by T2DM, often known as type 2 diabetes mellitus. This study looked at the relationship between elevated liver enzyme levels and the prevalence of T2DM in certain Iraqis. Only a small amount of research has been done on the connection between liver enzymes and T2DM.
Methods: In all, 80 people (40 with diabetes and 40 without) participated in the study. Blood serum was examined to determine the activity of alanine and aspartate aminotransferases (ALT, AST), -Glutamyl transpeptidase (GGT), and alkaline phosphatase (ALP). Fasting blood glucose (FBG) of less than 126 mg/dL or self-reported recent usage of insulin or anti-diabetic drugs were used to define T2DM.
Results: When compared to the non-diabetes group, the diabetic group's AST and ALP levels were considerably (P0.05) higher. In contrast, there was no difference in ALT (P>0.05). However, AST and ALT data based on gender revealed no statistically significant difference (P>0.05) between any of the groups for either enzyme. However, as compared to the non-diabetes male and female groups, the ALP enzyme findings showed that there was a significant increase (p0.05) in the diabetes male group.
Conclusions: T2DM patients frequently have increased liver enzyme levels.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Kalra, A., Yetiskul, E., Wehrle, C.J., and Tuma,F.(2021). .Physiology, Liver.. In: StatPearls [Internet]. Treasure Island (FL).
II. Lee ,D.H., Ha, M.H., Kim ,J.H., Christiani, D.C., Gross ,M.D., Steffes, M., Blomhoff, R., Jacobs, D.R. (2003). : Gamma-glutamyltransferase and diabetes-a 4 year follow-up study. Diabetologia. ; 46: 359-364.
III. Lee, D.H., Silventoinen, K., Jacobs ,D.R., Jousilahti, P. and Tuomileto, J. (2004). : Gamma-Glutamyltransferase, obesity, and the risk of type 2 diabetes: observational cohort study among 20,158 middle-aged men and women. J Clin Endocrinol Metab; 89: 5410-5414.
IV. Berk, P., & Korenblat, K. (2011). Approach to the Patient with Jaundice or Abnormal Liver Tests. In Goldman's Cecil Medicine: Twenty Fourth Edition (Vol. 1, pp. 956-966). Elsevier Inc.. https://doi.org/10.1016/B978-1-4377-1604-7.00149-4.
V. Ahn, H.R.., Shin, M.H., Nam, H.S. , Park, K.S. , Lee, Y.H., Jeong, S.K., Choi ,J.S. and Kweon,S.S. (2014). The association between liver enzymes and risk of type 2 diabetes: the Namwon study. Diabetol Metab Syndr; 6(14) .
VI. Wang ,Y., Koh ,W., Yuan, J. and Pan, A. (2016). Association between liver enzymes and incident type 2 diabetes in Singapore Chinese men and women ;BMJ Open Diabetes Research and Care 2016;4:e000296.
VII. Islam, S., Rahman, S., Haque, T., Sumon, A. H., Ahmed, A. M., & Ali, N. (2020). Prevalence of elevated liver enzymes and its association with type 2 diabetes: A cross-sectional study in Bangladeshi adults. Endocrinology, diabetes & metabolism, 3(2), e00116.
VIII. Noroozi Karimabad, M., Khalili, P., Ayoobi, F., Esmaeili-Nadimi, A., La Vecchia, C., & Jamali, Z. (2022). Serum liver enzymes and diabetes from the Rafsanjan cohort study. BMC endocrine disorders, 22(1), 127.
IX. Jha,S.K. , Yadav,N.K. and Rizal,S. (2021). Prevalence of elevated liver enzymes and its association with type 2 diabetes: A Descriptive Cross-Sectional Study among Nepalese Adults from Biratnagar, Nepal. Asian Journal of Medical Sciences ; 12(6) :50-55.
X. Alam, S., Raghav, A., Reyaz, A., Ahsan, A., Ahirwar, A. K., Jain, V., Agarwal, S., & Tripathi, P. (2021). Prevalence of elevated liver enzymes and its relationship with type 2 diabetes mellitus in North Indian adults. Metabolism open, 12, 100130.
XI. Meyhöfer ,S. , Eckert,A.J. Hummel ,M., Laimer ,M.,Roden ,M.,Kress ,S., Seufert ,J.,Meyhöfer ,S.M., Holl ,R.W.(2021). Elevated liver enzymes and comorbidities in type 2 diabetes: A multicentre analysis of 51 645 patients from the Diabetes Prospective Follow-up (DPV) database. Diabetes, Obesity and Metabolism: A Journal of Pharmacology and Therapeutics;24 (4) : 727-732.
XII. Wan, J.Y., Yang, L.Z. (2022). Liver Enzymes are Associated with Hyperglycemia in Diabetes: A Three-Year Retrospective Study. Diabetes Metab Syndr Obes.;15:545-555. https://doi.org/10.2147/DMSO.S350426.
XIII. Eltayeb, A. ., Faisal, S., Abdorabo, A., Ahmed, S., Gurashi, R., & Modawe, G. (2022). Evaluation of Liver Enzymes Activities among Type 2 Diabetic Patients, Attending Alribat University Hospital, Khartoum State: Evaluation of Liver Enzymes Activities among Type 2 Diabetic Patients. Iraqi National Journal of Medicine, 4(2), 251–259. https://doi.org/10.37319/iqnjm.4.2.9
XIV. Han, H. S., Kang, G., Kim, J. S., Choi, B. H., & Koo, S. H. (2016). Regulation of glucose metabolism from a liver-centric perspective. Experimental & molecular medicine, 48(3), e218.
https://doi.org/10.1038/emm.2015.122.
XV. Zhang, L., Ma, X., Jiang, Z., Zhang, K., Zhang, M., Li, Y., Zhao, X., & Xiong, H. (2015). Liver enzymes and metabolic syndrome: a large-scale case-control study. Oncotarget, 6(29), 26782–26788.
XVI. Al-Judaibi ,B. , Bain ,V.G., Sis,B. (2013). An Unusual Cause of Elevated Liver Enzymes in a Diabetic Patient. Clinical Challenges And Images In Gi; 144( 7) :1578. https://doi.org/10.1053/j.gastro.2013.01.061.
XVII. Belkacemi,L., and Belalia,M. (2016).Cross-sectional pilot study about the liver enzymes profile in type 2 diabetic patients from an Algerian west region: Wilaya of Mostaganem,Diabetes & Metabolic Syndrome: Clinical Research & Reviews; 10( 1), :S147-S150.
XVIII. Chen, S.CC., Tsai, S.P., Jhao, JY., Jiang, WK., Tsao,C.K. & Chang,LY. (2017). Liver Fat, Hepatic Enzymes, Alkaline Phosphatase and the Risk of Incident Type 2 Diabetes: A Prospective Study of 132,377 Adults. Sci Rep 7, 4649.
https://doi.org/10.1038/s41598-017-04631-7.
XIX. Moshtaghie , A. A., Taher, M. , Urogi , H., Emami , A., Amini , M. , Pourmoghadas , H., Taherian, A. , Facori , M. (2000). Interrelationship Between Blood Glucose Level And Incidence Of Bone Disease In Diabetes. Medical Journal of Islamic Academy of Sciences 13:3, 119-124.
XX. Deepika ,G., Veeraiah, N., Naveed, S., Ramana, M.V.( 2016). Serum alkaline phosphatase and high sensitivity C-reactive protein in type II diabetes mellitus: a risk of cardio vascular disease in South Indian population. Int J Res Med Sci;4: 1107- 14.
XXI. Sharma, U., Pal, D., & Prasad, R. (2014). Alkaline phosphatase: an overview. Indian journal of clinical biochemistry : IJCB, 29(3), 269–278. https://doi.org/10.1007/s12291-013-0408-y